Announced at CES 2026 for $449, the XREAL 1S brings 1,200p Micro-OLED displays with 700 nits of brightness and the X1 chip that lets you switch from 2D to 3D instantly. The optional Neo hub ($99 now, ...

Ahead of launching its first Android XR product, “Project Aura,” the new XREAL 1S glasses deliver some impressive new display upgrades, and for a lower price than its predecessor too. The XREAL 1S is ...

Posts from this topic will be added to your daily email digest and your homepage feed. Despite the spec bump, the Xreal 1S are $50 cheaper than their predecessor. Despite the spec bump, the Xreal 1S ...

I started with CNET reviewing laptops in 2009. Now I explore wearable tech, VR/AR, tablets, gaming and future/emerging trends in our changing world. Other obsessions include magic, immersive theater, ...

XREAL has announced the XREAL 1S, a replacement for its XREAL One AR glasses. The 1S glasses come with higher-resolution displays, a wider field of view, and more improvements. XREAL also announced ...

Looking for ways to slim down and improve your health? You've probably heard about GLP-1s — the buzzworthy prescription medication behind some of today's most talked-about weight loss stories. They've ...

Eli Lilly has shown patients maintained most of their weight loss after switching from injectable GLP-1s to its oral drug candidate, teeing the drugmaker up to target people taking Novo Nordisk’s ...

Share on Pinterest Research suggests that GLP-1 drugs likely have little to no effect on risk for obesity-related cancers. Image credit: James Manning – PA Images/Getty Images In 2022, about 2.5 ...

The 44-year-old tennis star opened up about her experience with GLP-1 medications in August after partnering with health care company Ro. She’s also teamed up with Lingo by Abbott, a continuous ...

During an interview with The New York Times, Stewart was asked about method acting after the conversation turned to Marlon Brando’s work on “Superman: The Movie.” The legendary actor reportedly would ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

SALT LAKE CITY — Weight-loss drugs have surged in popularity in recent years, with as many as 12% of Americans having tried a glucagon-like peptide-1 (GLP-1) medication such as Ozempic, Wegovy, ...